The best predictor of the future is what you have done in the past. ONCS has met every challenge and continues to show up at these conferences. You can't fake results even if they aren't perfect.
NeoPulse in phase 3 US had results as good as surgery with chemo - 8 monhts. Is that of value ?
NeoPulse phase 4 EUR had 94% success in killiing turmours in patients with no reoccurences during 8 month period Is that of value ? They use 1/20th the amount of toxic drug avoiding the
awful side effects which normally involve IV use of chemo agent. This is ready for the market, IMO
I would say, yes, this is a buying opportunity